GITNUXREPORT 2025

Remote And Hybrid Work In The Life Science Industry Statistics

Life sciences embrace remote work boosting collaboration, innovation, and cost savings.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

47% of life science companies have adopted cloud-based platforms for research data sharing

Statistic 2

41% of clinical trials incorporated decentralized elements in 2023

Statistic 3

43% of life sciences professionals used virtual reality for training purposes in 2023

Statistic 4

54% of clinical trials experienced delays due to inability to conduct onsite visits during the pandemic

Statistic 5

39% of clinical trial protocols have been adapted for remote patient monitoring

Statistic 6

31% of clinical trial sites reported difficulty in maintaining onsite staff

Statistic 7

40% of clinical research data was collected remotely in 2023, up from 15% in 2020

Statistic 8

63% of clinical trial participants prefer remote visit options

Statistic 9

46% of life science companies have faced regulatory challenges with remote monitoring

Statistic 10

55% of clinical trial sites use telemedicine for patient assessments

Statistic 11

55% of clinical trial participants experienced fewer interruptions when participating remotely

Statistic 12

53% of clinical trial sites report challenges in maintaining patient engagement remotely

Statistic 13

80% of research labs in life sciences have adopted digital lab notebooks for remote data entry

Statistic 14

62% of life science companies adopted hybrid work models in 2023

Statistic 15

73% of life science employees favor flexible working arrangements

Statistic 16

45% of R&D teams in life sciences report increased productivity due to remote work

Statistic 17

68% of life science executives believe remote work enhances collaboration

Statistic 18

85% of life science employees believe remote work improves work-life balance

Statistic 19

70% of leaders in life sciences say remote work has impacted their talent acquisition strategy

Statistic 20

60% of life sciences companies report challenges in managing remote teams

Statistic 21

55% of employees in life sciences believe that remote work reduces burnout

Statistic 22

67% of pharma R&D leaders see remote work as a means to talent retention

Statistic 23

75% of life science executives believe hybrid work models will become the standard

Statistic 24

29% of life science companies plan to reduce physical office space in the next year

Statistic 25

71% of life science companies report cost savings from remote work

Statistic 26

65% of pharmaceutical companies plan to increase remote work policies in 2024

Statistic 27

58% of life science companies view remote work as a key factor in global talent acquisition

Statistic 28

50% of R&D personnel work remotely at least 3 days a week

Statistic 29

74% of biotech companies believe remote work supports diversity and inclusion efforts

Statistic 30

72% of industry professionals see remote work as an opportunity to develop new skill sets

Statistic 31

48% of companies in the industry report cost savings from remote data collection

Statistic 32

66% of pharma companies increased their investment in digital tools during the pandemic

Statistic 33

80% of life science companies are exploring or implementing AI for data analysis

Statistic 34

70% of life science professionals believe that remote work has improved patient engagement in clinical trials

Statistic 35

59% of life science firms increased their use of digital twin technology

Statistic 36

49% of life sciences companies have increased data security investments due to remote work

Statistic 37

44% of pharmaceutical companies utilize virtual conferences for scientific exchange

Statistic 38

61% of life sciences companies are investing in remote data analytics tools

Statistic 39

59% of life science professionals use digital collaboration tools daily

Statistic 40

42% of life science firms plan to increase virtual meetings in 2024

Statistic 41

65% of research scientists in pharma believe remote work accelerates innovation

Statistic 42

30% of life science companies have implemented VR/AR for remote training and collaboration

Statistic 43

92% of respondents in a survey said digital transformation is critical for remote collaboration

Statistic 44

52% of clinical research professionals expect increased use of AI in remote trial management

Statistic 45

45% of researchers in the life sciences industry use remote access to lab data daily

Statistic 46

58% of life science companies increased their cybersecurity measures due to remote work

Statistic 47

83% of R&D teams have adopted digital collaboration tools in the last two years

Statistic 48

44% of life sciences firms report increased use of telehealth for patient consultations

Statistic 49

54% of life science professionals report faster decision-making with remote data access

Statistic 50

72% of biotech firms increased their use of cloud infrastructure during the pandemic

Statistic 51

38% of pharma sales representatives conduct virtual client meetings regularly

Statistic 52

49% of life science companies report increased efficiency due to remote team collaboration

Statistic 53

69% of life sciences R&D teams report faster project timelines due to remote access to data

Statistic 54

53% of industry leaders see remote work as a driver for technological innovation

Statistic 55

76% of clinical research coordinators report increased patient recruitment through remote strategies

Statistic 56

34% of life sciences firms are planning to implement more remote data collection tools

Statistic 57

64% of companies see a positive impact on innovation with remote collaborative tools

Statistic 58

66% of research teams report more effective cross-departmental collaboration remotely

Statistic 59

78% of R&D leaders view remote work as a strategic advantage

Slide 1 of 59

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

62% of life science companies adopted hybrid work models in 2023
73% of life science employees favor flexible working arrangements
45% of R&D teams in life sciences report increased productivity due to remote work
68% of life science executives believe remote work enhances collaboration
54% of clinical trials experienced delays due to inability to conduct onsite visits during the pandemic
59% of life science professionals use digital collaboration tools daily
48% of companies in the industry report cost savings from remote data collection
85% of life science employees believe remote work improves work-life balance
39% of clinical trial protocols have been adapted for remote patient monitoring
42% of life science firms plan to increase virtual meetings in 2024
65% of research scientists in pharma believe remote work accelerates innovation
30% of life science companies have implemented VR/AR for remote training and collaboration
70% of leaders in life sciences say remote work has impacted their talent acquisition strategy

Remote and hybrid work are transforming the life science industry in 2023, with 62% of companies embracing flexible models, 73% of employees favoring them, and significant boosts in productivity, collaboration, and innovation shaping the future of medical research and development.

Adoption of Technology and Innovation

47% of life science companies have adopted cloud-based platforms for research data sharing
41% of clinical trials incorporated decentralized elements in 2023
43% of life sciences professionals used virtual reality for training purposes in 2023

Adoption of Technology and Innovation Interpretation

The life science industry is progressively embracing digital innovation, with nearly half of the companies adopting cloud platforms, a growing number integrating decentralized trials, and virtual reality revolutionizing training—highlighting a shift where science meets seamless technology.

Clinical Trials and Research Challenges

54% of clinical trials experienced delays due to inability to conduct onsite visits during the pandemic
39% of clinical trial protocols have been adapted for remote patient monitoring
31% of clinical trial sites reported difficulty in maintaining onsite staff
40% of clinical research data was collected remotely in 2023, up from 15% in 2020
63% of clinical trial participants prefer remote visit options
46% of life science companies have faced regulatory challenges with remote monitoring
55% of clinical trial sites use telemedicine for patient assessments
55% of clinical trial participants experienced fewer interruptions when participating remotely
53% of clinical trial sites report challenges in maintaining patient engagement remotely

Clinical Trials and Research Challenges Interpretation

As the life science industry navigates the pandemic-era balance of remote innovation and onsite hurdles, these statistics reveal a pivotal shift toward remote trial methods—raising hopes for greater efficiency and participant convenience, but also highlighting regulatory and engagement challenges that demand strategic solutions.

Digital Transformation

80% of research labs in life sciences have adopted digital lab notebooks for remote data entry

Digital Transformation Interpretation

With 80% of life science research labs embracing digital lab notebooks for remote data entry, it's clear that even in the tightest scientific circles, going digital isn't just a trend—it's the new standard for keeping research both innovative and accessible.

Employee and Workforce Preferences

62% of life science companies adopted hybrid work models in 2023
73% of life science employees favor flexible working arrangements
45% of R&D teams in life sciences report increased productivity due to remote work
68% of life science executives believe remote work enhances collaboration
85% of life science employees believe remote work improves work-life balance
70% of leaders in life sciences say remote work has impacted their talent acquisition strategy
60% of life sciences companies report challenges in managing remote teams
55% of employees in life sciences believe that remote work reduces burnout
67% of pharma R&D leaders see remote work as a means to talent retention
75% of life science executives believe hybrid work models will become the standard
29% of life science companies plan to reduce physical office space in the next year
71% of life science companies report cost savings from remote work
65% of pharmaceutical companies plan to increase remote work policies in 2024
58% of life science companies view remote work as a key factor in global talent acquisition
50% of R&D personnel work remotely at least 3 days a week
74% of biotech companies believe remote work supports diversity and inclusion efforts
72% of industry professionals see remote work as an opportunity to develop new skill sets

Employee and Workforce Preferences Interpretation

As the life science industry pivots toward hybrid models embraced by 75% of leaders—fueling cost savings, talent retention, and a healthier work-life balance—it's clear that remote work isn't just a paradigm shift but a strategic catalyst, even as 60% grapple with managing its complexities.

Industry Investment and Cost Savings

48% of companies in the industry report cost savings from remote data collection
66% of pharma companies increased their investment in digital tools during the pandemic
80% of life science companies are exploring or implementing AI for data analysis
70% of life science professionals believe that remote work has improved patient engagement in clinical trials
59% of life science firms increased their use of digital twin technology
49% of life sciences companies have increased data security investments due to remote work
44% of pharmaceutical companies utilize virtual conferences for scientific exchange
61% of life sciences companies are investing in remote data analytics tools

Industry Investment and Cost Savings Interpretation

As the life science industry harnesses digital innovation—from AI and virtual conferences to digital twins and remote data analytics—it's clear that while remote work is reshaping cost structures and patient engagement, safeguarding data remains the vigilant counterpart to this tech-forward transformation.

Remote Work and Digital Transformation

59% of life science professionals use digital collaboration tools daily
42% of life science firms plan to increase virtual meetings in 2024
65% of research scientists in pharma believe remote work accelerates innovation
30% of life science companies have implemented VR/AR for remote training and collaboration
92% of respondents in a survey said digital transformation is critical for remote collaboration
52% of clinical research professionals expect increased use of AI in remote trial management
45% of researchers in the life sciences industry use remote access to lab data daily
58% of life science companies increased their cybersecurity measures due to remote work
83% of R&D teams have adopted digital collaboration tools in the last two years
44% of life sciences firms report increased use of telehealth for patient consultations
54% of life science professionals report faster decision-making with remote data access
72% of biotech firms increased their use of cloud infrastructure during the pandemic
38% of pharma sales representatives conduct virtual client meetings regularly
49% of life science companies report increased efficiency due to remote team collaboration
69% of life sciences R&D teams report faster project timelines due to remote access to data
53% of industry leaders see remote work as a driver for technological innovation
76% of clinical research coordinators report increased patient recruitment through remote strategies
34% of life sciences firms are planning to implement more remote data collection tools
64% of companies see a positive impact on innovation with remote collaborative tools
66% of research teams report more effective cross-departmental collaboration remotely
78% of R&D leaders view remote work as a strategic advantage

Remote Work and Digital Transformation Interpretation

In an industry where precision and innovation reign supreme, life science professionals are increasingly leveraging digital collaboration tools—over half using them daily and asserting that remote work accelerates discovery—proving that in the quest for breakthrough treatments, virtual is quickly becoming as vital as the lab bench.